Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803 Xia LiuJingze WangChangling Li PRECLINICAL STUDIES 10 July 2007 Pages: 505 - 517
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors Sandra MuellerUlrike HartmannCarsten Bokemeyer PRECLINICAL STUDIES 30 May 2007 Pages: 519 - 524
Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile F. C. VasconcelosC. R. GattassR. C. Maia PRECLINICAL STUDIES 23 May 2007 Pages: 525 - 533
Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity Giovanni PetrilloCarla FenoglioMaurizio Viale PRECLINICAL STUDIES 16 June 2007 Pages: 535 - 544
A phase II clinical trial of ZD1839 (Iressaâ„¢) in combination with docetaxel as first-line treatment in patients with advanced breast cancer Sheri K. DennisonSamuel A. JacobsSandra M. Swain PHASE II STUDIES 12 June 2007 Pages: 545 - 551
A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium M. J. MackenzieD. SaltmanM. J. Moore PHASE II STUDIES 22 June 2007 Pages: 553 - 558
Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer Elisabetta CampagnoliIsabella GarassinoRaffaele Cavina PHASE II STUDIES 19 June 2007 Pages: 559 - 564
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel Tomasz M. BeerCelestia S. HiganoAlison L. Hannah PHASE II STUDIES 07 July 2007 Pages: 565 - 570
Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients Sandra BeijerEric A. R. GielissePieter C. Dagnelie PHASE III STUDIES Open access 05 September 2007 Pages: 571 - 579